序号 |
标题 |
次数 |
作者 |
发布时间 |
87166 |
DOTA-RGD,DOTA多肽衍生物 |
144 |
kx |
2024-11-21 |
87167 |
DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 |
110 |
zcy |
2024-11-21 |
87168 |
DOTA-丙烯酰胺,DOTA Acrylamide |
103 |
kx |
2024-11-21 |
87169 |
DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide |
103 |
zyl |
2024-11-21 |
87170 |
1262403-91-7,七肽DOTA-YLYEIAR,螯合物前体肽 |
97 |
kx |
2024-11-21 |
87171 |
DOTA-8-AOC-BBN (7-14)NH2 NOTA-共轭铃蟾肽衍生物 |
104 |
zcy |
2024-11-21 |
87172 |
多叠氮基聚乙二醇衍生物(PEGn(N3))m |
93 |
WYQ |
2024-11-21 |
87173 |
DOTA derivative,CAS号:153777-70-9 |
88 |
zyl |
2024-11-21 |
87174 |
多炔基聚乙二醇衍生物(PEGn(C≡CH))m |
132 |
WYQ |
2024-11-21 |
87175 |
173308-19-5,DOTA-(COOt-Bu)3-C2-NH2 |
85 |
kx |
2024-11-21 |
87176 |
DOTA-ADIBO,CAS号:1374865-01-6 |
92 |
zyl |
2024-11-21 |
87177 |
端炔基聚乙二醇(PEG-alk) |
178 |
WYQ |
2024-11-21 |
87178 |
Gd-DOTA-HCBP(多肽核磁共振成像(MRI)探针) |
105 |
zyl |
2024-11-21 |
87179 |
NOTA-IPB-PDL1P PET成像分子探针 |
98 |
zcy |
2024-11-21 |
87180 |
DOTA大环化合物,Tm-DOTA,CAS号78063-83-9 |
105 |
zyl |
2024-11-21 |
87181 |
DOTA-E[c(RGDyK)2],金属离子螯合剂 |
107 |
kx |
2024-11-21 |
87182 |
DOTA-8-AOC-BOMBESIN(7-14)NH2 DOTA-8-AOC-铃蟾肽(7-14)氨基 |
97 |
zcy |
2024-11-21 |
87183 |
DOTA-Arg-Gly-Asp-Ser-Pro-Lys-COOH |
136 |
kx |
2024-11-21 |
87184 |
GGG-PEG4-DOTA |
87 |
zyl |
2024-11-21 |
87185 |
叠氮化四乙酰基葡萄糖(TAGP-N3) |
110 |
WYQ |
2024-11-21 |
87186 |
DOTA-SP(4-11) DOTA偶联神经肽P物质(SP) |
93 |
zcy |
2024-11-21 |
87187 |
叠氮端基聚(γ-苄基-L-谷氨酸酯)(PBLG-N3) |
176 |
WYQ |
2024-11-21 |
87188 |
DOTA-E[cyclo(RGDfK)2] |
88 |
kx |
2024-11-21 |
87189 |
DOTA-(COOt-Bu)3-NHS,819869-77-7 |
90 |
zyl |
2024-11-21 |
87190 |
三乙炔基苯由一个苯环和三个乙炔基取代基组成 |
192 |
WYQ |
2024-11-21 |
87191 |
DOTA-JR11,1039726-31-2是多肽分子探针前体 |
102 |
zyl |
2024-11-21 |
87192 |
DOTA-3/F11 DOTA标记的抗PSMA单克隆抗体3/F11 |
90 |
zcy |
2024-11-21 |
87193 |
DOTA-Tyr-Lys-DOTA大环化合物-多肽链 |
90 |
kx |
2024-11-21 |
87194 |
DOTA-cyclo(RGDfK) |
94 |
zyl |
2024-11-21 |
87195 |
DOTA-6G-RGD4 DOTA标记的环RGD肽 |
121 |
zcy |
2024-11-21 |
87196 |
DOTA多肽试剂1306310-00-8 |
107 |
zyl |
2024-11-21 |
87197 |
250612-06-7,DOTA多肽探针二聚体 |
86 |
kx |
2024-11-21 |
87198 |
DOTA-[D-Asp26,Nle28,31]-CCK(26-33) DOTA偶联非硫酸化CCK八肽类似物 |
119 |
zcy |
2024-11-21 |
87199 |
DOTA-GGGA,149206-86-0 |
93 |
zyl |
2024-11-21 |
87200 |
DOTA功能螯合剂标记多肽 |
140 |
kx |
2024-11-21 |
87201 |
3-双(叠氮甲基)环氧丁烷-四氢呋喃(BAMO-THF) |
146 |
WYQ |
2024-11-21 |
87202 |
DOTA-[Pro~1, Tyr~4]-bombesin 缀合肽DOTA-[Pro~1,Tyr ~ 4]-铃蟾肽 |
107 |
zcy |
2024-11-21 |
87203 |
DOTA大环化合物,Tm-DOTA,CAS号78063-83-9 |
143 |
zyl |
2024-11-21 |
87204 |
端炔基遥爪型聚酰亚胺(API) |
181 |
WYQ |
2024-11-21 |
87205 |
Dotatate(DOTA-octreotide),大环配体多肽 |
135 |
kx |
2024-11-21 |
87206 |
端炔基的线形聚(N-异丙基丙烯酰胺)(alkynylPNIPAM) |
148 |
WYQ |
2024-11-21 |
87207 |
DOTA-PEG-RGD |
109 |
zyl |
2024-11-21 |
87208 |
1,5-二叠氮基-3-硝基-3-氮杂戊烷(DIANP) |
119 |
WYQ |
2024-11-21 |
87209 |
β-炔基-氟磺酰基烷烃(BAFSAs) |
196 |
WYQ |
2024-11-21 |
87210 |
金属离子螯合剂DOTA功能化量子点 |
168 |
kx |
2024-11-21 |